Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2022
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Reconciliation and Canada’s overdose crisis: responding to the needs of Indigenous Peoples

Jennifer Lavalley, Shelda Kastor, Jenna Valleriani and Ryan McNeil
CMAJ December 17, 2018 190 (50) E1466-E1467; DOI: https://doi.org/10.1503/cmaj.181093
Jennifer Lavalley
British Columbia Centre on Substance Use (Lavalley, Kastor, Valleriani, McNeil); Western Aboriginal Harm Reduction Society (Kastor); Department of Medicine (Valleriani, McNeil), University of British Columbia, St. Paul’s Hospital, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shelda Kastor
British Columbia Centre on Substance Use (Lavalley, Kastor, Valleriani, McNeil); Western Aboriginal Harm Reduction Society (Kastor); Department of Medicine (Valleriani, McNeil), University of British Columbia, St. Paul’s Hospital, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenna Valleriani
British Columbia Centre on Substance Use (Lavalley, Kastor, Valleriani, McNeil); Western Aboriginal Harm Reduction Society (Kastor); Department of Medicine (Valleriani, McNeil), University of British Columbia, St. Paul’s Hospital, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryan McNeil
British Columbia Centre on Substance Use (Lavalley, Kastor, Valleriani, McNeil); Western Aboriginal Harm Reduction Society (Kastor); Department of Medicine (Valleriani, McNeil), University of British Columbia, St. Paul’s Hospital, Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
KEY POINTS
  • Canada’s drug overdose crisis disproportionately affects Indigenous Peoples differently owing to a legacy of colonialism, racism and intergenerational trauma.

  • Disaggregated data on Indigenous people are needed to understand more clearly how Indigenous Peoples are affected by drug overdoses.

  • Indigenizing harm reduction and addiction treatment must involve integrating cultural and traditional Indigenous values that align with the principles of harm reduction.

  • Reconciliation with Indigenous Peoples must include ending the war on drugs to address underlying structural conditions that produce drug-related harms, including overdose.

The Government of Canada’s commitment to address, through the Truth and Reconciliation Commission, the systemic oppression of Indigenous Peoples has occurred alongside an overdose crisis that disproportionately affects the same population. Far too many First Nations, Métis and Inuit (Indigenous) people who use drugs are dying from drug overdoses, and Canada must pursue Indigenous-specific solutions to address this growing crisis.

In Canada, there were about 4000 opioid-related deaths in 2017.1 In British Columbia, the mortality rate for Indigenous people who use drugs is 5 times higher than for other drug users. Despite representing just 2.6% of the total population, Indigenous Peoples account for 10% of overdose deaths.2,3 Indigenous women are 8 times more likely to have a nonfatal overdose and 5 times more likely to have a fatal overdose than non-Indigenous women.3 The severity of this crisis is likely understated owing to poor disaggregation of data on Indigenous Peoples in many settings.

The devastating effects of the war on drugs have been widely documented,4,5 and yet Canada, as a recent signatory to the US Global Call to Action on the World Drug Problem, has supported a renewal of this approach.6 The war on drugs has disproportionately targeted Indigenous Peoples and people of colour and resulted in substantial health and social harms, including an increase in overdoses.5 Factors that increase vulnerability to drug-related harms for Indigenous Peoples are framed by the historical and ongoing traumas related to colonization, including the residential school experience, poverty and child apprehension and involvement in the child welfare system, as well as inadequate access to education, health services and social supports.7–10 The war on drugs intersects with, and reinforces, the oppression and racialized violence that shape the everyday experiences of Indigenous people who used drugs. Overpolicing and high rates of incarceration of this population, and other minorities,3 is not evidence based and violates human rights.

So far, the federal government’s responses to the overdose crisis have been insufficient to address the underlying structural drivers of the overdose crisis among Indigenous Peoples. Lack of support from policy-makers and all levels of government is also a major problem.

It is clear that drug decriminalization must be central to the Government of Canada’s reconciliation with Indigenous Peoples. While drugs remain criminalized, strides toward addressing the overdose epidemic among Indigenous people who use drugs will remain futile. Although harm reduction interventions — syringe exchange programs, supervised consumption sites and naloxone distribution — are being scaled up across Canada, drug criminalization and policing practices constrain their effectiveness. Canada must move on from the failed drug policies that have devastated Indigenous communities. It is imperative, however, that governments include Indigenous stakeholders and organizations when determining the future of Canada’s drug policy, as is consistent with the government’s commitment to reconciliation.4 Decriminalization policies should involve expunging criminal records as well as committing to reparations in Indigenous communities for those directly harmed by the drug war.

Alongside decriminalization, reconciliation must involve investing in Indigenous communities, including upstream investments addressing social-structural drivers of health inequities that contribute to the problem of drug overdose deaths among Indigenous Peoples. Although both federal and provincial/territorial governments have dedicated funding to address the opioid overdose crisis, Indigenous-specific funding has not been prioritized and is urgently needed. A public health approach to better supporting Indigenous Peoples who use drugs will require a commitment to Indigenizing harm reduction and addiction treatment policies, practices and supports by incorporating traditional Indigenous values. It also requires recognizing the impacts of colonialism and institutional racism, while acknowledging the strengths, abilities and inherent rights of Indigenous Peoples, and addressing the underlying conditions that drive high rates of overdose, such as those related to family, housing and access to health care.

Discourses about who qualifies as Indigenous limit how data on Indigenous people are collected. Data on Métis, Inuit and those living on reserves are scarce.3 This may mask the severity of the overdose crisis among Indigenous people who use drugs, placing Indigenous communities at increased long-term risk. This shortcoming must be addressed and, within broader themes of self-governance and self-determination, data collection on overdoses and related outcomes among Indigenous Peoples must be owned and controlled by Indigenous Peoples.11 Data collection frameworks and strategies at the BC First Nations Health Authority may be a model to emulate countrywide.

Reconciliation in Canada requires drug policy reform that combats systems creating trauma, accounts for the legacy of colonization and dismantles the structural forms of racism shaping Canada’s drug policies. Promises to solve the opioid overdose crisis that do not involve decriminalization will never address the deep racial disparities and injustices faced by Indigenous Peoples. To ignore the experiences of Indigenous communities in the context of the overdose crisis is nothing short of a public health failure.

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

  • Contributors: All authors contributed to the conceptualization of the work. Jennifer Lavelley and Ryan McNeil wrote the initial draft. All authors revised it critically for important intellectual content, gave final approval of the version to be published and agreed to be accountable for all aspects of the work.

  • Funding: This work was funded by the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research, and the National Institute on Drug Abuse (US Department of Health and Human Services, National Institutes of Health; grant no. R01DA044181).

References

  1. ↵
    Special Advisory Committee on the Epidemic of Opioid Overdoses. National report: Apparent opioid-related deaths in Canada (January 2016 to December 2017) [Web-based report]. Ottawa: Public Health Agency of Canada; June 2018; modified 2018 Sept. 18. Available: www.canada.ca/en/public-health/services/publications/healthy-living/national-report-apparent-opioid-related-deaths-released-june-2018.html (accessed 2018 Oct. 22).
  2. ↵
    Table 3: Distribution of First Nations people, First Nations people with and without registered Indian status, and First Nations people with registered Indian status living on or off reserve, Canada, provinces and territories, 2011. Ottawa: Statistics Canada; modified 2015 Dec. 23. Available: www12.statcan.gc.ca/nhs-enm/2011/as-sa/99-011-x/2011001/tbl/tbl03-eng.cfm (accessed 2018 Aug. 3).
  3. ↵
    Overdose data and First Nations in BC: preliminary findings. West Vancouver (BC): First Nations Health Authority, 2017.
  4. ↵
    1. Marshall SG
    . Canadian drug policy and the reproduction of Indigenous inequities. The International Indigenous Policy Journal 2015;6:7.
    OpenUrl
  5. ↵
    1. Wood E,
    2. Werb D,
    3. Marshall BDL,
    4. et al
    . The war on drugs: a devastating public-policy disaster. Lancet 2009;373:989–90.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Nolen S
    . Canada signs on to U.S.-led renewal of war on drugs. Globe and Mail [Toronto] 2018 Sept. 24; updated 2018 Sept. 25. Available: www.theglobeandmail.com/world/article-canada-signs-on-to-us-led-renewal-of-war-on-drugs/ (accessed 2018 Oct. 10).
  7. ↵
    1. Allan B,
    2. Smylie J
    . First Peoples, second class treatment: the role of racism in the health and well-being of Indigenous peoples in Canada. Toronto: Wellesley Institute; 2015.
    1. Reading CL,
    2. Wien F
    . Health inequalities and the social determinants of Aboriginal peoples’ health. Prince George (BC): National Collaborating Centre for Aboriginal Health; 2009.
    1. Goodman A,
    2. Fleming K,
    3. Markwick N,
    4. et al.
    Western Aboriginal Harm Reduction Society. “They treated me like crap and I know it was because I was Native”: the healthcare experiences of Aboriginal peoples living in Vancouver’s inner city. Soc Sci Med 2017;178:87–94.
    OpenUrl
  8. ↵
    1. Browne AJ
    . Moving beyond description: closing the health equity gap by redressing racism impacting Indigenous populations. Soc Sci Med 2017;184:23–6.
    OpenUrl
  9. ↵
    Ownership, Control, Access and Possession (OCAP): the path to First Nations information governance. Ottawa: The First Nations Information Governance Centre; 2014.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 190 (50)
CMAJ
Vol. 190, Issue 50
17 Dec 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reconciliation and Canada’s overdose crisis: responding to the needs of Indigenous Peoples
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Reconciliation and Canada’s overdose crisis: responding to the needs of Indigenous Peoples
Jennifer Lavalley, Shelda Kastor, Jenna Valleriani, Ryan McNeil
CMAJ Dec 2018, 190 (50) E1466-E1467; DOI: 10.1503/cmaj.181093

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Reconciliation and Canada’s overdose crisis: responding to the needs of Indigenous Peoples
Jennifer Lavalley, Shelda Kastor, Jenna Valleriani, Ryan McNeil
CMAJ Dec 2018, 190 (50) E1466-E1467; DOI: 10.1503/cmaj.181093
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans
  • Google Scholar

More in this TOC Section

  • Antiracist practice for pediatric surgeons in Canada
  • Understanding and addressing Islamophobia through trauma-informed care
  • Dismantling gendered Islamophobia in medicine
Show more Commentary

Similar Articles

Collections

  • Areas of Focus
    • Vulnerable populations
  • Topics
    • Aboriginal health
    • Canadian government
    • Health policy
    • Pharmacology & toxicology
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2022, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire